These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 30922818)

  • 1. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis.
    van Eijk AM; Larsen DA; Kayentao K; Koshy G; Slaughter DEC; Roper C; Okell LC; Desai M; Gutman J; Khairallah C; Rogerson SJ; Hopkins Sibley C; Meshnick SR; Taylor SM; Ter Kuile FO
    Lancet Infect Dis; 2019 May; 19(5):546-556. PubMed ID: 30922818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation.
    Figueroa-Romero A; Bissombolo D; Meremikwu M; Ratsimbasoa A; Sacoor C; Arikpo I; Lemba E; Nhama A; Rakotosaona R; Llach M; Pons-Duran C; Sanz S; Ma L; Doderer-Lang C; Maly C; Roman E; Pagnoni F; Mayor A; Menard D; González R; Menéndez C
    Lancet Glob Health; 2023 Nov; 11(11):e1765-e1774. PubMed ID: 37858587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
    Chaponda EB; Mharakurwa S; Michelo C; Bruce J; Chandramoha D; Matthew Chico R
    Malar J; 2021 Jan; 20(1):61. PubMed ID: 33482823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis.
    Chico RM; Cano J; Ariti C; Collier TJ; Chandramohan D; Roper C; Greenwood B
    Trop Med Int Health; 2015 Dec; 20(12):1621-33. PubMed ID: 26325263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained clinical benefit of malaria chemoprevention with sulfadoxine-pyrimethamine (SP) in pregnant women in a region with high SP resistance markers.
    Matambisso G; Brokhattingen N; Maculuve S; Cístero P; Mbeve H; Escoda A; Bambo G; Cuna B; Melembe C; Ndimande N; Tetteh KKA; Drakeley C; Gamain B; Chitnis C; Chauhan V; Quintó L; Macete E; Mayor A
    J Infect; 2024 May; 88(5):106144. PubMed ID: 38574776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
    Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP
    Malar J; 2007 Nov; 6():144. PubMed ID: 17996048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
    Eisele TP; Larsen DA; Anglewicz PA; Keating J; Yukich J; Bennett A; Hutchinson P; Steketee RW
    Lancet Infect Dis; 2012 Dec; 12(12):942-9. PubMed ID: 22995852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women.
    Gutman J; Kalilani L; Taylor S; Zhou Z; Wiegand RE; Thwai KL; Mwandama D; Khairallah C; Madanitsa M; Chaluluka E; Dzinjalamala F; Ali D; Mathanga DP; Skarbinski J; Shi YP; Meshnick S; ter Kuile FO
    J Infect Dis; 2015 Jun; 211(12):1997-2005. PubMed ID: 25564249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana.
    Mama A; Ahiabor C; Tornyigah B; Frempong NA; Kusi KA; Adu B; Courtin D; Houzé S; Deloron P; Ofori MF; Anang AK; Ariey F; Ndam NT
    Malar J; 2022 Mar; 21(1):107. PubMed ID: 35346205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
    Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis.
    Roh ME; Kuile FOT; Rerolle F; Glymour MM; Shiboski S; Gosling R; Gutman J; Kakuru A; Desai M; Kajubi R; L'Ianziva A; Kamya MR; Dorsey G; Chico RM
    Lancet Glob Health; 2020 Jul; 8(7):e942-e953. PubMed ID: 32562650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of malaria in pregnancy.
    Desai M; Hill J; Fernandes S; Walker P; Pell C; Gutman J; Kayentao K; Gonzalez R; Webster J; Greenwood B; Cot M; Ter Kuile FO
    Lancet Infect Dis; 2018 Apr; 18(4):e119-e132. PubMed ID: 29395997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990-2020.
    Flegg JA; Humphreys GS; Montanez B; Strickland T; Jacome-Meza ZJ; Barnes KI; Raman J; Guerin PJ; Hopkins Sibley C; Dahlström Otienoburu S
    PLoS Comput Biol; 2022 Aug; 18(8):e1010317. PubMed ID: 35951528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial.
    Madanitsa M; Barsosio HC; Minja DTR; Mtove G; Kavishe RA; Dodd J; Saidi Q; Onyango ED; Otieno K; Wang D; Ashorn U; Hill J; Mukerebe C; Gesase S; Msemo OA; Mwapasa V; Phiri KS; Maleta K; Klein N; Magnussen P; Lusingu JPA; Kariuki S; Mosha JF; Alifrangis M; Hansson H; Schmiegelow C; Gutman JR; Chico RM; Ter Kuile FO
    Lancet; 2023 Mar; 401(10381):1020-1036. PubMed ID: 36913959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi.
    Taylor SM; Levitt B; Freedman B; Madanitsa M; Thwai KL; Kalilani-Phiri L; Khairallah C; Mwapasa V; Ter Kuile FO; Meshnick SR
    J Infect Dis; 2020 Jul; 222(4):661-669. PubMed ID: 32221555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.